A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.

Maglakelidze, Marina; ...; Andric, Zoran G; Nikolic, Ivan V; ...; Radosavljevic, Davorin Z; Petrovic, Zoran; ...; (broj, koautora 17)

Rezultati

eNauka > Rezultati > A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.

Naziv:	A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.
Autori:	Maglakelidze, Marina; ...; Andric, Zoran G ; Nikolic, Ivan V ; ...; Radosavljevic, Davorin Z ; Petrovic, Zoran; ...; (broj, koautora 17)
Godina:	2021
Publikacija:	CANCER RESEARCH
ISSN:	0008-5472 Cancer Research Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 81 br. 13 str. CT107
WoS-ID:	000680263501246
URI:	https://enauka.gov.rs/handle/123456789/805596
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
Napomena:	Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, APR 10-MAY 21, 2021
M-kategorija:	Mp kategorija će biti prikazana naknadno.

2
WEB OF SCIENCE^TM

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.